JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNeill, J. H.
Right arrow Articles by Brody, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeill, J. H.
Right arrow Articles by Brody, T. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ATROPINE
*COCAINE
*LIOTHYRONINE
*RESERPINE
*TYRAMINE
Journal of Pharmacology And Experimental Therapeutics, Vol. 161, Issue 1, 40-46, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF TRIIODOTHYRONINE PRETREATMENT ON AMINE-INDUCED RAT CARDIAC PHOSPHORYLASE ACTIVATION

John H. McNeill 1 and Theodore M. Brody 1

1 Department of Pharmacology, Michigan State University, East Lansing, Michigan

The purpose of the present study was to determine the effect of triiodothyronine (T3) pretreatment on amine-induced rat cardiac phosphorylase activation and to determine whether the thyroid-amine interaction could be explained on the basis of blockade of amine uptake. Pretreatment of rats with T3 (500 mg/kg daily for 3 days) resulted in an increase in cardiac phosphorylase a. In addition, the animals showed a marked enhancement of the effect of norepinephrine, isoproterenol or tyramine infusion on cardiac phosphorylase a. The administration of cocaine to T3-pretreated animals resulted in a further enhancement of the norepinephrine effect but not of the isoproterenol effect. Pretreatment of animals with reserpine did not affect control enzyme levels or the response to norepinephrine in control animals but did decrease phosphorylase a in T3-pretreated animals to control levels. Animals pretreated with reserpine and T3 exhibited a marked sensitivity to norepinephrine. All increases in phosphorylase a caused by drug treatments could be blocked or decreased by propranolol. The propranolol blockade was unaffected by atropine. It is concluded that T3 pretreatment potentiates the effect of norepinephrine, isoproterenol and tyramine on phosphorylase a. T3 potentiation is not the result of blockade of amine uptake.

Submitted on November 27, 1967
Accepted on January 18, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.